Zane Starkewolfe

Zane Starkewolfe is an accomplished Director in Corporate Development & Investment at WuXi Biologics since April 2020, focusing on corporate venture investments in the United States, board roles, strategic partnerships, and new business initiatives. Previous experience includes Director of Corporate Development, Associate Director of Venture Catalyst at the University of California, Davis, Board Member at Myto Therapeutics, and various roles in investment banking and venture capital. Zane co-founded companies such as NanoRX and Mesolytics, where innovative medical technologies were developed. Educational credentials include a PhD in Chemistry and a BS in Physics, both from the University of California, Davis.